SCHEMBL24319367

SCHEMBL24319367

CN1CCC(CN2CCC(N(C)C)CC2)CC1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.42
ACHE P22303 1/20 0.41
CHRM5 P08912 1/20 0.38
ADRA2C P18825 1/20 0.38
CACNA2D1 P54289 1/20 0.38
CACNA1B Q00975 1/20 0.38
CACNB1 Q02641 1/20 0.38
CACNA1C Q13936 1/20 0.38
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35
NOS2 P35228 1/20 0.35
GNAI3 P08754 1/20 0.33
GNAO1 P09471 1/20 0.33
GNAI1 P63096 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17753773 0.88 ACHE (0.47) ACHECHRM5ADRA2CNOS3NOS1
SCHEMBL23267306 0.85 CHRM5 (0.38) NCF1ACHECHRM5ADRA2CCACNA2D1
SCHEMBL13874610 0.84 ACHE (0.59) ACHECHRM5ADRA2CNOS3NOS1
SCHEMBL3439900 0.82 ACHE (0.62) ACHECHRM5ADRA2C
SCHEMBL24319371 0.82 NCF1 (0.37) NCF1ACHECHRM5ADRA2CCACNA2D1
SCHEMBL24319476 0.81 NCF1 (0.50) NCF1ACHECHRM5ADRA2CCACNA2D1
SCHEMBL23173902 0.81 NCF1 (0.54) NCF1ACHECHRM5ADRA2CCACNA2D1
SCHEMBL25571706 0.81 NCF1 (0.54) NCF1ACHECHRM5ADRA2CCACNA2D1
SCHEMBL46703 0.81 L3MBTL3 (0.42) NCF1KDM4EALDH1A1
SCHEMBL25489110 0.80 ACHE (0.38) ACHECHRM5ADRA2CNOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022047145-A1 RAPIDLY ACCELERATING FIBROSARCOMA PROTEIN DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2022-03-03 WO disclosed